310 related articles for article (PubMed ID: 21351575)
1. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
[TBL] [Abstract][Full Text] [Related]
3. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
Pan J; Lu W; Li C; Wang S; He L
Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
[TBL] [Abstract][Full Text] [Related]
4. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
5. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
6. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Pradhan R; Kim YI; Chang SW; Kim JO
Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery.
Mehuys E; Vervaet C; Gielen I; Van Bree H; Remon JP
J Control Release; 2004 Apr; 96(2):261-71. PubMed ID: 15081217
[TBL] [Abstract][Full Text] [Related]
10. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
11. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
Siddique S; Bose A; Khanam J
Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
Yan G; Li H; Zhang R; Ding D
Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
[TBL] [Abstract][Full Text] [Related]
13. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
Boyapally H; Nukala RK; Douroumis D
Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
[TBL] [Abstract][Full Text] [Related]
14. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
Wu B; Deng D; Lu Y; Wu W
Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
17. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
Ishida M; Abe K; Hashizume M; Kawamura M
Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
[TBL] [Abstract][Full Text] [Related]
20. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
